The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1730-1736

  Nojiri, Keiichiro ^a   Sugimoto, Kazushi ^a   Shiraki, Katsuya ^a   Tameda, Masahiko ^a   Inagaki, Yuuji ^a   Kusagawa, Satoko ^a   Ogura, Suguru ^a   Tanaka, Junichiro ^a   Yoneda, Misao ^a   Yamamoto, Norihiko ^a   Okano, Hiroshi ^a   Takei, Yoshiyuki ^a   Ito, Masaaki ^a   Kasai, Chika ^a   Inoue, Hidekazu ^a   Takase, Koujiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Colon cancer; Toll like receptor

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED RNA; DOXORUBICIN; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; ANTINEOPLASTIC AGENT; CPG-OLIGONUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGODEOXYRIBONUCLEOTIDE; TLR3 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER TISSUE; CARCINOMA CELL; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; AGONISTS; CELL MEMBRANE; COLON TUMOR; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOXORUBICIN; HUMANS; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; POLY I-C; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 9;

EID: 84895639283     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2322     Document Type: Article

References (22)

1. Takeda K, Kaisho T and Akira S: Toll-like receptors. Annu Rev Immunol 21: 335-376, 2003. (Pubitemid 37174535)
2. Takeda K and Akira S: Toll-like receptors in innate immunity. Int Immunol 17: 1-14, 2005.
3. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, et al: Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24: 353-389, 2006.
4. Akira S. Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell 124: 783-801, 2006. (Pubitemid 43261452)
5. Bauer S, Kirschning CJ, Häcker H, Redecke V, Hausmann S, Akira S, Wagner H and Lipford GB: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 98: 9237-9242, 2001. (Pubitemid 32743900)
6. Becker MN, Diamond G, Verghese MW and Randell SH: CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 275: 29731-29736, 2000. (Pubitemid 32043854)
7. Faure E, Thomas L, Xu H, Medvedev A, Equils O and Arditi M: Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 166: 2018-2024, 2001. (Pubitemid 32114690)
8. Barton GM, Kagan JC and Medzhitov R: Intracellular localization of Toll-like receptor 9 prevents recognition of self-DNA but facilitates access to viral DNA. Nat Immunol 7: 49-56, 2006. (Pubitemid 41823868)
9. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K and Akira S: Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643, 2003. (Pubitemid 36927946)
10. Alexopoulou L, Holt AC, Medzhitov R and Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738, 2001. (Pubitemid 33009951)
11. Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E and Giladi H: TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 100: 1301-1312, 2007. (Pubitemid 46480411)
12. Huang B, Zhao J, Unkeless JC, Feng ZH and Xiong H: TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224, 2008.
13. Yu L and Chen S: Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother 57: 1271-1278, 2008.
14. Sato Y, Goto Y, Narita N and Hoon DS: Cancer cells expressing Toll-like receptors and the tumor microenvironment. Cancer Microenviron 2: 205-214, 2009.
15. Yoneda K, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Fuke H, Yamamoto N, Masuya M, Horie R, Uchida K and Takei Y: Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: Differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. Int J Oncol 33: 929-936, 2008.
16. Tanaka J, Sugimoto K, Shiraki K, Tameda M, Kusagawa S, Nojiri K, Beppu T, Yoneda K, Yamamoto N, Uchida K, Kojima T and Takei Y: Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas. Int J Oncol 37: 805-814, 2010.
17. Sun R, Zhang Y, Lv Q, Liu B, Jin M, Zhang W, He Q, Deng M, Liu X, Li G, Li Y, Zhou G, Xie P, Xie X, Hu J and Duan Z: Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem 286: 15918-15928, 2011.
18. Salaun B, Lebecque S, Matikainen S, Rimoldi D and Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13: 4565-4574, 2007. (Pubitemid 47219727)
19. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC and Taniguchi T: Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 101: 15416-15421, 2004. (Pubitemid 39441556)
20. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O and Akira S: Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5: 1061-1068, 2004. (Pubitemid 41057726)
21. Karin M, Cao Y, Greten FR and Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310, 2002. (Pubitemid 37328783)
22. Ghosh S and Karin M: Missing pieces in the NF-κB puzzle. Cell 109: S81-S96, 2002.